Jakub Jończyk

1.4k total citations · 1 hit paper
41 papers, 1.1k citations indexed

About

Jakub Jończyk is a scholar working on Computational Theory and Mathematics, Pharmacology and Molecular Biology. According to data from OpenAlex, Jakub Jończyk has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Computational Theory and Mathematics, 26 papers in Pharmacology and 17 papers in Molecular Biology. Recurrent topics in Jakub Jończyk's work include Computational Drug Discovery Methods (27 papers), Cholinesterase and Neurodegenerative Diseases (26 papers) and Alzheimer's disease research and treatments (9 papers). Jakub Jończyk is often cited by papers focused on Computational Drug Discovery Methods (27 papers), Cholinesterase and Neurodegenerative Diseases (26 papers) and Alzheimer's disease research and treatments (9 papers). Jakub Jończyk collaborates with scholars based in Poland, Czechia and Slovenia. Jakub Jończyk's co-authors include Barbara Malawska, Justyna Godyń, Dawid Panek, Marek Bajda, Anna Więckowska, Stanislav Gobec, Damijan Knez, Tomasz Wichur, Anna Pasieka and Muhammad Yar and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Jakub Jończyk

36 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic strategies for Alzheimer's disease in clinical trials

2015 356 citations Justyna Godyń, Jakub Jończyk et al. Pharmacological Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jakub Jończyk Poland	17	576	414	373	336	336	41	1.1k
Dawid Panek Poland	16	703 1.2×	480 1.2×	344 0.9×	445 1.3×	304 0.9×	24	1.2k
Zonghua Luo United States	18	632 1.1×	366 0.9×	345 0.9×	282 0.8×	402 1.2×	38	1.2k
Justyna Godyń Poland	17	656 1.1×	454 1.1×	321 0.9×	362 1.1×	302 0.9×	35	1.1k
Preet Anand India	10	680 1.2×	346 0.8×	306 0.8×	244 0.7×	566 1.7×	12	1.4k
Elena Simoni Italy	20	792 1.4×	491 1.2×	415 1.1×	343 1.0×	396 1.2×	29	1.3k
Piyoosh Sharma India	19	680 1.2×	494 1.2×	418 1.1×	340 1.0×	411 1.2×	34	1.5k
Prabhash Nath Tripathi India	17	678 1.2×	474 1.1×	378 1.0×	356 1.1×	361 1.1×	31	1.3k
Nasimul Hoda India	21	498 0.9×	375 0.9×	508 1.4×	232 0.7×	646 1.9×	47	1.5k
Ankit Seth India	14	495 0.9×	353 0.9×	251 0.7×	256 0.8×	208 0.6×	29	957
Pavan Srivastava India	13	545 0.9×	376 0.9×	319 0.9×	292 0.9×	315 0.9×	15	1.1k

Countries citing papers authored by Jakub Jończyk

Since Specialization

Citations

This map shows the geographic impact of Jakub Jończyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jakub Jończyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jakub Jończyk more than expected).

Fields of papers citing papers by Jakub Jończyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jakub Jończyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jakub Jończyk. The network helps show where Jakub Jończyk may publish in the future.

Co-authorship network of co-authors of Jakub Jończyk

This figure shows the co-authorship network connecting the top 25 collaborators of Jakub Jończyk. A scholar is included among the top collaborators of Jakub Jończyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jakub Jończyk. Jakub Jończyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Czopek, Anna, et al.. (2025). In vitro repositioning therapy with olaparib, temozolomide and oxaliplatin in glioblastoma cell lines: U118, U87, U251, H4 and human fibroblasts. Pharmacological Reports. 77(6). 1716–1726.

Mordyl, Barbara, Joanna Śniecikowska, Jakub Jończyk, et al.. (2025). Targeting GABAergic Hypofunction Associated with Schizophrenia: Identification of α1β2γ2GABA-A Receptor Ligands with Neuroprotective and Antipsychotic Properties. ACS Chemical Neuroscience. 16(12). 2277–2294.

Czopek, Anna, et al.. (2025). Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives. ACS Chemical Neuroscience. 16(12). 2163–2177.

Jończyk, Jakub, Joanna Drzeżdżon, Dagmara Jacewicz, et al.. (2022). Synthesis, In Vitro, and Computational Studies of PTP1B Phosphatase Inhibitors Based on Oxovanadium(IV) and Dioxovanadium(V) Complexes. International Journal of Molecular Sciences. 23(13). 7034–7034. 4 indexed citations

Jończyk, Jakub, et al.. (2022). Mining Literature-Based Knowledge Graph for Predicting Combination Therapeutics: A COVID-19 Use Case. Homo Politicus (Academy of Humanities and Economics in Lodz). 14. 79–86. 1 indexed citations

Andrýs, Rudolf, Jakub Jończyk, David Maliňák, et al.. (2021). Pyridinium-2-carbaldoximes with quinolinium carboxamide moiety are simultaneous reactivators of acetylcholinesterase and butyrylcholinesterase inhibited by nerve agent surrogates. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 437–449. 3 indexed citations

Jończyk, Jakub, Annika Frank, Holger Stark, et al.. (2021). Guanidine Derivatives: How Simple Structural Modification of Histamine H₃R Antagonists Has Led to the Discovery of Potent Muscarinic M₂R/M₄R Antagonists. ACS Chemical Neuroscience. 12(13). 2503–2519. 12 indexed citations

Jończyk, Jakub, et al.. (2021). Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase. Biomolecules. 11(2). 169–169. 7 indexed citations

Pasieka, Anna, Dawid Panek, Jakub Jończyk, et al.. (2021). Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. European Journal of Medicinal Chemistry. 218. 113397–113397. 16 indexed citations

10.

Jończyk, Jakub, Justyna Godyń, Beata Morak‐Młodawska, et al.. (2020). Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity. Molecules. 25(11). 2604–2604. 15 indexed citations

11.

Czarnecka, Kamila, Robert Skibiński, Jakub Jończyk, et al.. (2020). New Tetrahydroacridine Hybrids with Dichlorobenzoic Acid Moiety Demonstrating Multifunctional Potential for the Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 21(11). 3765–3765. 6 indexed citations

12.

Godyń, Justyna, Jakub Jończyk, Anna Pasieka, et al.. (2020). Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1944–1952. 15 indexed citations

13.

Jończyk, Jakub, et al.. (2020). Structure modeling of γ-aminobutyric acid transporters – Molecular basics of ligand selectivity. International Journal of Biological Macromolecules. 158. 1380–1389. 14 indexed citations

14.

Czarnecka, Kamila, Robert Skibiński, Jakub Jończyk, et al.. (2019). Discovery of New Cyclopentaquinoline Analogues as Multifunctional Agents for the Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 20(3). 498–498. 12 indexed citations

15.

Wichur, Tomasz, Anna Więckowska, Krzysztof Więckowski, et al.. (2019). 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease. European Journal of Medicinal Chemistry. 187. 111916–111916. 45 indexed citations

16.

Panek, Dawid, Anna Więckowska, Anna Pasieka, et al.. (2018). Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents. Molecules. 23(2). 347–347. 35 indexed citations

17.

Panek, Dawid, Anna Więckowska, Jakub Jończyk, et al.. (2018). Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents. ACS Chemical Neuroscience. 9(5). 1074–1094. 49 indexed citations

18.

Czarnecka, Kamila, Robert Skibiński, Jakub Jończyk, et al.. (2018). Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment. European Journal of Medicinal Chemistry. 145. 760–769. 17 indexed citations

19.

Jończyk, Jakub, Barbara Malawska, & Marek Bajda. (2017). Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification. PLoS ONE. 12(10). e0186108–e0186108. 16 indexed citations

20.

Jończyk, Jakub, Natalia Guzior, Marek Bajda, et al.. (2014). Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(1). 98–106. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact